DAFNA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | KALV | 423K | $5.15M |
 | CYTK | 395K | $21.71M |
 | OBIO | 364K | $901.82K |
 | LXEO | 358K | $2.38M |
 | TNDM | 355K | $4.31M |
 | ERAS | 350K | $763.00K |
 | ATXS | 320K | $2.33M |
 | BCAX | 317K | $5.01M |
 | BDTX | 307K | $1.16M |
 | XENE | 288K | $11.56M |
 | CGEN | 272K | $400.43K |
 | BHVN | 235K | $3.53M |
 | IMTX | 235K | $2.00M |
 | MRUS | 220K | $20.76M |
 | BCRX | 218K | $1.66M |
 | EWTX | 214K | $3.47M |
 | IMVT | 191K | $3.09M |
 | AUTL | 179K | $292.29K |
 | STOK | 170K | $3.99M |
 | DNLI | 169K | $2.45M |
KalVista Pharmaceuticals, Inc.
KALV
Shares Held
423K
Value
$5.15M
Cytokinetics, Incorporated
CYTK
Shares Held
395K
Value
$21.71M
Orchestra BioMed Holdings, Inc.
OBIO
Shares Held
364K
Value
$901.82K
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
358K
Value
$2.38M
Tandem Diabetes Care, Inc.
TNDM
Shares Held
355K
Value
$4.31M
Erasca, Inc.
ERAS
Shares Held
350K
Value
$763.00K
Astria Therapeutics, Inc.
ATXS
Shares Held
320K
Value
$2.33M
Bicara Therapeutics Inc. Common Stock
BCAX
Shares Held
317K
Value
$5.01M
Black Diamond Therapeutics, Inc.
BDTX
Shares Held
307K
Value
$1.16M
Xenon Pharmaceuticals Inc.
XENE
Shares Held
288K
Value
$11.56M
Compugen Ltd.
CGEN
Shares Held
272K
Value
$400.43K
Biohaven Ltd.
BHVN
Shares Held
235K
Value
$3.53M
Immatics N.V.
IMTX
Shares Held
235K
Value
$2.00M
Merus N.V.
MRUS
Shares Held
220K
Value
$20.76M
BioCryst Pharmaceuticals, Inc.
BCRX
Shares Held
218K
Value
$1.66M
Edgewise Therapeutics, Inc.
EWTX
Shares Held
214K
Value
$3.47M
Immunovant, Inc.
IMVT
Shares Held
191K
Value
$3.09M
Autolus Therapeutics plc
AUTL
Shares Held
179K
Value
$292.29K
Stoke Therapeutics, Inc.
STOK
Shares Held
170K
Value
$3.99M
Denali Therapeutics Inc.
DNLI
Shares Held
169K
Value
$2.45M